
Ontario aware bike lane removals may not reduce congestion, could make people less safe: internal documents
CBC
Ontario's premier and transportation minister have said for months that removing bike lanes is a necessary measure to reduce traffic in the GTA. But hundreds of pages of internal ministry documents, reports and emails show the government is aware the move may not have a meaningful impact on congestion and could increase collisions for everyone who uses roads.
The heavily-redacted documents were made public as part of a court challenge to the legislation — Bill 212 would see bike lanes on Bloor Street, Yonge Street and University Avenue removed — mounted by the charity Cycle Toronto in Toronto.
The documents were used in an argument for an injunction Tuesday to prevent any bike lane removal work until the court challenge is heard in full in April.
The documents include a presentation on a legislative plan for a "pro-driver package" and emails between Ministry of Transportation Ontario (MTO) staff that cast doubt on the ability to achieve bikes lanes on secondary streets as the minister publicly promised.
There is also a report prepared by the engineering and urban planning firm CIMA+ for MTO that says collisions for all road users could increase by upwards of 54 per cent when bike lanes are removed, based on prior research.
"There is a medium risk that the proposed change will not achieve the desired outcomes," reads a 2024 cabinet office committee briefing note.
"Given that current data and research does not confirm that removing bike lanes that occupy a lane of traffic would significantly alleviate congestion."
An October briefing that asks what sections of the Bloor, Yonge and University lanes should be removed notes that the MTO did not own the "data required to support a decision to remove a bike lane."
The cyclists mounting the court challenge say the documents reveal that MTO has privately been aware of what many critics have been saying about the legislation: that it won't solve Toronto's traffic issues, will make people unsafe, and there is no readily available network of secondary roads to replace the targeted routes.
At the injunction hearing Tuesday, the lawyer for the province said Ontario will have lots of documents and evidence to argue its rationale when the court challenge is heard in full in April. On the CIMA+ report specifically, which outlines an increased collision risk, Padraic Ryan argued the report was a high-level commentary with no original analysis.
The CIMA+ work for the province is broken down into two phases, per the documents. The first phase, which is where the 54 per cent increase in collisions figure comes from, was a review of relevant research and case studies. A second phase of research, with site-specific safety analysis, is not included in the recently released batch of documents.
The report says based on previous research, bike infrastructure can reduce collisions between 35 per cent to 50 per cent. It notes the increase in collisions could be reduced if less people bike on the roads where the bike lanes are removed, but cyclists may start riding on sidewalks instead — increasing risk for pedestrians.
"I want to make sure that the bikers are safe," Premier Doug Ford said in November. "I have always believed that you don't put [bike lanes] on main arterial roads, you put them on secondary roads."
Ford and Prabmeet Sarkaria, his transportation minister, have repeatedly promised that ripped out bike lanes would be replaced by bike lanes on parallel streets to give cyclists another option. A solution that has been criticized by cyclists who say routes can't be replaced on smaller roads without making someone's trip significantly longer and less direct.

Five years after COVID-19 was first detected in Manitoba, experts say the province still has a ways to go to fully address the effects of the pandemic and set itself up to respond better in future emergencies — from the impact the pandemic had on mental health and trust in public health information, to the long-term effects of the illness and the amount of surveillance data about it now available to the public.